An In Vivo Model of Human Macrophages in Metastatic Melanoma
暂无分享,去创建一个
W. J. Valente | J. Bielas | R. Gottardo | R. Pierce | D. Byrd | A. Rongvaux | Stephanie Weaver | K. McKenna | V. Voillet | Jean S. Campbell | K. Smythe | A. Chapuis | Teresa S. Kim | K. Paulson | Trisha R. Berger | W. Tan | D. Hunter | J. Campbell
[1] J. Linton,et al. Building the Next Generation of Humanized Hemato-Lymphoid System Mice , 2021, Frontiers in Immunology.
[2] L. Zon,et al. Melanoma models for the next generation of therapies. , 2021, Cancer cell.
[3] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[4] Xueda Hu,et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells , 2021, Cell.
[5] Xianwen Ren,et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma , 2019, Cell.
[6] Andrew J. Hill,et al. The single cell transcriptional landscape of mammalian organogenesis , 2019, Nature.
[7] I. Amit,et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma , 2019, Cell.
[8] A. Rongvaux,et al. Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models. , 2019, Blood advances.
[9] J. Schultze,et al. The Myeloid Cell Compartment-Cell by Cell. , 2019, Annual review of immunology.
[10] Zemin Zhang,et al. Understanding tumor ecosystems by single-cell sequencing: promises and limitations , 2018, Genome biology.
[11] Monika S. Kowalczyk,et al. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade , 2018, Cell.
[12] Carola Berking,et al. Melanoma , 2018, The Lancet.
[13] P. Bousso,et al. A human immune system mouse model with robust lymph node development , 2018, Nature Methods.
[14] Jennifer L. Guerriero. Macrophages: The Road Less Traveled, Changing Anticancer Therapy. , 2018, Trends in molecular medicine.
[15] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[16] J. Banchereau,et al. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Yiling Lu,et al. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. , 2017, Cell reports.
[18] Hannah A. Pliner,et al. Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.
[19] K. Flaherty,et al. Targeted agents and immunotherapies: optimizing outcomes in melanoma , 2017, Nature Reviews Clinical Oncology.
[20] R. Weinberg,et al. Emerging Biological Principles of Metastasis , 2017, Cell.
[21] Hans Clevers,et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts , 2017, Nature Reviews Cancer.
[22] I. Mellman,et al. Elements of cancer immunity and the cancer–immune set point , 2017, Nature.
[23] D. Gabrilovich. Myeloid-Derived Suppressor Cells , 2017, Cancer Immunology Research.
[24] Grace X. Y. Zheng,et al. Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.
[25] M. Manz,et al. Generation of Humanized Mice for Analysis of Human Dendritic Cells. , 2016, Methods in molecular biology.
[26] R. Medzhitov,et al. Tissue biology perspective on macrophages , 2015, Nature Immunology.
[27] M. Haniffa,et al. Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species? , 2015, Front. Immunol..
[28] P. Linsley,et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.
[29] R. Siliciano,et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations , 2015, Nature.
[30] F. Ginhoux,et al. New insights into the multidimensional concept of macrophage ontogeny, activation and function , 2015, Nature Immunology.
[31] I. Amit,et al. Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment , 2014, Cell.
[32] J. Stender,et al. Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities , 2014, Cell.
[33] Florent Ginhoux,et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.
[34] Cole Trapnell,et al. Pseudo-temporal ordering of individual cells reveals dynamics and regulators of cell fate decisions , 2014, Nature Biotechnology.
[35] A. Palucka,et al. Development and function of human innate immune cells in a humanized mouse model , 2014, Nature Biotechnology.
[36] S. Gordon,et al. The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.
[37] Tom C. Freeman,et al. Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.
[38] Sandra Romero-Steiner,et al. Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines , 2013, Nature Immunology.
[39] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[40] R. Flavell,et al. Human hemato-lymphoid system mice: current use and future potential for medicine. , 2013, Annual review of immunology.
[41] Alberto Mantovani,et al. Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.
[42] R. Flavell,et al. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. , 2011, Trends in immunology.
[43] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[44] D. Gabrilovich,et al. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.
[45] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[46] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[47] Jeffrey E Gershenwald,et al. Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] H. Møller,et al. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] R. DePinho,et al. BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.
[50] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[51] Markus G. Manz,et al. Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.
[52] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[53] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[54] P. Romero,et al. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. , 1998, Journal of immunology.